Agendia Genomic Test for Molecular Subtyping of Breast Cancer Is a Better Guide to Pre-Surgical Treatment Study Finds
News
A new study entitled “Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)“ and published in the Annals of Surgical Oncology, ... Read more